GobyMeds vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
GobyMeds beats MEDVi overall, scoring 8.4/10 vs 7.7/10. GobyMeds is more affordable at $99/mo vs $299/mo. Choose GobyMeds for budget-conscious users who want a modern, well-reviewed comp. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side comparison of GobyMeds and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
GobyMeds
#4 of 40Fast-growing compounded GLP-1 provider with strong Reddit reviews, competitive pricing, and a clean user experience that punches above its price point.
Visit GobyMedsMEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | GobyMeds | MEDVi |
|---|---|---|
| Our Score | 8.4/10 | 7.7/10 |
| Starting Price | $99/mo | $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Budget-conscious users who want a modern, well-reviewed compounded GLP-1 program | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #4 | #21 |
Pros & Cons Compared
GobyMeds
Pros
- +$119/mo starting price is among the most affordable for a full-service compounded program
- +Consistently positive Reddit reviews citing fast shipping, responsive support, and clean UX
- +Modern patient portal with real-time order tracking and easy provider messaging
- +Quick onboarding — most patients approved and shipped within 48 hours of enrollment
Cons
- −Compounded semaglutide only — no tirzepatide, no brand-name, no oral options
- −Newer company with less track record than established players like Ro or Hims
- −No insurance billing and no superbills for FSA/HSA reimbursement
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
GobyMeds edges out MEDVi with a score of 8.4/10 vs 7.7/10. If budget is your priority, GobyMeds starts at $99/mo compared to MEDVi's $299/mo. Choose GobyMeds if you want: budget-conscious users who want a modern, well-reviewed compounded glp-1 program. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.